Whether the salmon industry can continue to reap the rewards of its recent programme of huge investments is set to be one of the subjects covered in an illuminating presentation by Kolbjørn Giskeødegård on 29 May.
In this two-part feature, The Fish Site and Mike Selden, CEO of the cell-based fish company Finless Foods, discuss the background of lab-grown fish and the origins of Finless Foods bluefin tuna.
Mowi farm technician Clara McGhee discusses the main fish health challenges facing Scottish salmon farmers, the range of methods used to resolve them and some of the gross misconceptions surrounding the sector.
Extreme weather events and changing ocean conditions are creating unpredictable outcomes for aquaculture. One area where research is offering some insight into what to expect, though, is the increasing incidences of disease.
Despite struggling to achieve bulk production volumes and compete with global commodities such as fishmeal and soy, opportunities for alternative protein producers in aquafeed sector are only going to grow in the coming years.
Salmon rendered sterile through gene editing are exhibiting encouraging behaviour and performance during the grow-out phase, according to new research results.
Ways to commercialise the production of finfish rendered sterile by novel methods sparked a thought-provoking discussion at the end of the inaugural International Finfish Sterility Workshop, which was held in Stirling this week.
